As for younger patients with T2DM, the International Society of Pediatric and Adolescent Diabetes (ISPAD) [5] recommends initial pharmacologic treatment with MET and insulin, either alone or in combination, depending on the degree of metabolic disturbances, as well as hyperglycemic and ketosis incidence. The gene discussed is INS; the disease is type 2 diabetes mellitus.